MCA2

MCA2 (PF3D7_1438400) is a Plasmodium cysteine protease that functions in stage-specific development and stress-linked, apoptosis-like death programs across the parasite life cycle (PMID:29317266, PMID:35264080). Enzymatically it behaves as an arginine/lysine-specific protease rather than a canonical caspase: it cleaves z-GRR-AMC but not caspase substrates, and is blocked by Z-FA-FMK but not by general caspase inhibitors (PMID:29317266). Catalysis depends on a Cys157-His205 dyad, while recognition and cleavage of its natural substrate, Tudor staphylococcal nuclease (PfTSN), requires both Cys157 and the non-conserved Tyr224, defining a non-canonical substrate-binding mode distinct from the residues needed for peptide-substrate turnover (PMID:29317266, PMID:35670460). MCA2 is expressed in schizonts and gametocytes (PMID:29317266) and localizes to the Kelch13 compartment in asexual blood stages (PMID:38039338). Genetic knockout in P. berghei establishes that MCA2 is required for gametocyte formation, for maintaining oocyst, ookinete, and sporozoite numbers, and for timely hepatocyte invasion (PMID:35264080). Pharmacological inhibition by selective small molecules blocks parasite growth and mosquito transmission and triggers oxidative stress, mitochondrial depolarization, Ca2+ accumulation, phosphatidylserine externalization, and DNA fragmentation, marking an apoptosis-like death phenotype (PMID:29317266, PMID:32202613, PMID:35264080). Beyond these findings, the direct functional consequence of MCA2's Kelch13-compartment residence and the downstream signaling of PfTSN cleavage have not been characterized in the available corpus.

1. 2018 Medium

   Established whether MCA2 is a true caspase or a distinct protease, resolving its enzymatic identity and defining a natural substrate.

   Evidence Fluorogenic peptide assays, inhibitor profiling, and in vitro cleavage of PfTSN in P. falciparum

   PMID:29317266

   Open questions at the time

   • Structural basis of Arg/Lys specificity not resolved
   • Physiological role of PfTSN cleavage not defined
   • Single-lab in vitro characterization
2. 2018 Medium

   Linked MCA2 expression to specific life-cycle stages and connected its activity to an apoptosis-like death phenotype upon inhibition.

   Evidence Stage-specific Western blot, Z-FA-FMK growth inhibition, and apoptosis-marker flow cytometry in P. falciparum

   PMID:29317266

   Open questions at the time

   • Z-FA-FMK is not MCA2-selective, so death phenotype attribution is indirect
   • Molecular effectors of the death program not identified
3. 2020 Medium

   Determined that selective chemical inhibition of MCA2 alone drives an oxidative, mitochondrial, and Ca2+ death cascade, sharpening causal attribution to the enzyme.

   Evidence SS-5 inhibitor with a specificity panel, ROS/mitochondrial/Ca2+ assays in P. falciparum, and in vivo P. berghei model

   PMID:32202613

   Open questions at the time

   • Order of ROS, mitochondrial, and Ca2+ events not established
   • Direct in-parasite target engagement of SS-5 not shown
   • Single lab
4. 2021 Medium

   Mapped the catalytic and substrate-recognition residues, showing that PfTSN engagement uses a non-canonical mode distinct from peptide-substrate catalysis.

   Evidence Site-directed mutagenesis of Cys157/His205/Tyr224 with in vitro and in vivo PfTSN cleavage assays in P. falciparum

   PMID:35670460

   Open questions at the time

   • No structure of the MCA2-PfTSN complex
   • Broader substrate repertoire beyond PfTSN unknown
5. 2022 High

   Defined the genetic requirement for MCA2 across the life cycle, establishing roles in gametocytogenesis, mosquito-stage development, and hepatocyte invasion, and its value as a transmission-blocking target.

   Evidence P. berghei gene knockout with life-cycle-stage quantification, plus C-532/C-533 inhibition and mosquito transmission assays in P. falciparum and P. berghei

   PMID:35264080

   Open questions at the time

   • Molecular substrates driving each developmental defect not identified
   • Mechanistic basis of delayed hepatocyte invasion unknown
6. 2023 Medium

   Placed MCA2 spatially within the Kelch13 compartment, associating it with host-cytosol endocytosis and artemisinin-relevant biology in asexual stages.

   Evidence BioID proximity labeling, co-localization imaging, and AlphaFold2 domain analysis in P. falciparum

   PMID:38039338

   Open questions at the time

   • Functional consequence of K13-compartment residence not tested
   • Whether MCA2 contributes to artemisinin susceptibility unknown
7. 2024 Low

   Connected MCA2 to a stress-responsive transcriptional program, showing its induction under ER stress and drug pressure.

   Evidence Transcriptional analysis of PbMCA2 after tunicamycin, 5-fluorouracil, and chloroquine treatment in ex vivo P. berghei

   PMID:38976068

   Open questions at the time

   • Transcript-only, no protein or functional confirmation for MCA2
   • Causal link between induction and the death program not established

• How MCA2's protease activity and PfTSN cleavage mechanistically drive gametocytogenesis, mosquito-stage development, and the oxidative apoptosis-like cascade remains unresolved.
• No structure of MCA2 or its substrate complex
• Full in vivo substrate repertoire unknown
• Functional role of K13-compartment localization untested